LB Pharmaceuticals Valuation
| LBRX Stock | 23.78 0.23 0.96% |
At this time, the entity appears to be overvalued. LB Pharmaceuticals Common owns a latest Real Value of USD22.8 per share. The recent price of the entity is USD23.78. Our model forecasts the value of LB Pharmaceuticals Common from analyzing the entity fundamentals such as EBITDA of (63.01 M), shares owned by insiders of 0.27 %, and Shares Outstanding of 25.3 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting LB Pharmaceuticals' valuation include:
Overvalued
Today
Please note that LB Pharmaceuticals' price fluctuation is not too volatile at this time. Calculation of the real value of LB Pharmaceuticals Common is based on 3 months time horizon. Increasing LB Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since LB Pharmaceuticals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of LBRX Stock. However, LB Pharmaceuticals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 23.78 | Real 22.8 | Hype 23.78 | Naive 23.72 |
The intrinsic value of LB Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence LB Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of LB Pharmaceuticals Common helps investors to forecast how LBRX stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of LB Pharmaceuticals more accurately as focusing exclusively on LB Pharmaceuticals' fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use LB Pharmaceuticals' intrinsic value based on its ongoing forecasts of LB Pharmaceuticals' financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against LB Pharmaceuticals' closest peers.
LB Pharmaceuticals Cash |
|
LB Pharmaceuticals Total Value Analysis
LB Pharmaceuticals Common is now projected to have valuation of 294.34 M with market capitalization of 607.43 M, debt of 3.7 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the LB Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
294.34 M | 607.43 M | 3.7 M |
LB Pharmaceuticals Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of LBRX suggests not a very effective usage of assets in March.LB Pharmaceuticals Profitability Analysis
Based on LB Pharmaceuticals' profitability indicators, LB Pharmaceuticals Common may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in April. Profitability indicators assess LB Pharmaceuticals' ability to earn profits and add value for shareholders.Net Loss | First Reported 2010-12-31 | Previous Quarter -56.8 M | Current Value -54 M | Quarterly Volatility 17.5 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Return On Equity | 0.36 | 0.6 |
|
|
For LB Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of LB Pharmaceuticals Common to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well LB Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between LB Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of LB Pharmaceuticals over time as well as its relative position and ranking within its peers.
LB Pharmaceuticals Earnings per Share Projection vs Actual
By analyzing LB Pharmaceuticals' earnings estimates, investors can diagnose different trends across LB Pharmaceuticals' analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for LB Pharmaceuticals Common is based on EPS before non-recurring items and includes expenses related to employee stock options.LB Pharmaceuticals Ownership Allocation
LB Pharmaceuticals Common secures a total of 25.3 Million outstanding shares. The majority of LB Pharmaceuticals Common outstanding shares are owned by institutions. These other corporate entities are usually referred to as non-private investors looking to shop for positions in LB Pharmaceuticals Common to benefit from reduced commissions. Hence, outside corporations are subject to a different set of regulations than regular investors in LB Pharmaceuticals Common. Please pay attention to any change in the institutional holdings of LB Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.LB Pharmaceuticals Profitability Analysis
Net Loss for the year was (63.1 M) with profit before overhead, payroll, taxes, and interest of 0.About LB Pharmaceuticals Valuation
Our relative valuation model uses a comparative analysis of LB Pharmaceuticals. We calculate exposure to LB Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of LB Pharmaceuticals's related companies.LB Pharmaceuticals Current Valuation Indicators
Valuation refers to the process of determining the present value of LB Pharmaceuticals Common and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value LBRX we look at many different elements of the entity such as LBRX's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as LB Pharmaceuticals, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use LB Pharmaceuticals' valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes LB Pharmaceuticals' worth.Additional Tools for LBRX Stock Analysis
When running LB Pharmaceuticals' price analysis, check to measure LB Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LB Pharmaceuticals is operating at the current time. Most of LB Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of LB Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LB Pharmaceuticals' price. Additionally, you may evaluate how the addition of LB Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.